AACR 2021: Investigational Tebentafusp Improves Survival in Metastatic Uveal Melanoma
Practice-changing trial is the first to demonstrate overall survival benefit in this disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.